Wataru Tomeno

2.3k total citations · 1 hit paper
36 papers, 1.6k citations indexed

About

Wataru Tomeno is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Wataru Tomeno has authored 36 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Epidemiology, 18 papers in Hepatology and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Wataru Tomeno's work include Liver Disease Diagnosis and Treatment (32 papers), Diet, Metabolism, and Disease (7 papers) and Liver Disease and Transplantation (7 papers). Wataru Tomeno is often cited by papers focused on Liver Disease Diagnosis and Treatment (32 papers), Diet, Metabolism, and Disease (7 papers) and Liver Disease and Transplantation (7 papers). Wataru Tomeno collaborates with scholars based in Japan, Italy and United States. Wataru Tomeno's co-authors include Masato Yoneda, Satoru Saito, Kento Imajo, Atsushi Nakajima, Yuji Ogawa, Takaomi Kessoku, Yasushi Honda, Koji Fujita, Hironori Mawatari and Koichiro Wada and has published in prestigious journals such as Gastroenterology, PLoS ONE and Scientific Reports.

In The Last Decade

Wataru Tomeno

34 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography

2015 598 citations Kento Imajo, Takaomi Kessoku et al. Gastroenterology profile →

Peers

Countries citing papers authored by Wataru Tomeno

Since Specialization

Citations

This map shows the geographic impact of Wataru Tomeno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wataru Tomeno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wataru Tomeno more than expected).

Fields of papers citing papers by Wataru Tomeno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wataru Tomeno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wataru Tomeno. The network helps show where Wataru Tomeno may publish in the future.

Co-authorship network of co-authors of Wataru Tomeno

This figure shows the co-authorship network connecting the top 25 collaborators of Wataru Tomeno. A scholar is included among the top collaborators of Wataru Tomeno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wataru Tomeno. Wataru Tomeno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Meta‐analysis of the diagnostic accuracy of serum type IV collagen 7S concentration for the staging of liver fibrosis in nonalcoholic fatty liver disease 2022 ·Hepatology Research ·Yasushi Honda, Masato Yoneda, Takashi Kobayashi, Michihiro Iwaki, (unknown), Asako Nogami, Takaomi Kessoku, Yuji Ogawa, Wataru Tomeno, Kento Imajo, Nobuyuki Horita, Satoru Saito, Takeshi Kaneko, Atsushi Nakajima	1
2	Protective effect of SGL5213, a potent intestinal sodium–glucose cotransporter 1 inhibitor, in nonalcoholic fatty liver disease in mice 2021 ·Journal of Pharmacological Sciences ·Yasushi Honda, Anna Ozaki, Michihiro Iwaki, Takashi Kobayashi, Asako Nogami, Takaomi Kessoku, Yuji Ogawa, Wataru Tomeno, Kento Imajo, Masato Yoneda, Satoru Saito, Yoji Nagashima, Atsushi Nakajima	6
3	Efficacy, safety, and tolerability of lubiprostone for the treatment of non-alcoholic fatty liver disease in adult patients with constipation: The LUBIPRONE, double-blind, randomised, placebo-controlled study design 2018 ·Contemporary Clinical Trials ·Takaomi Kessoku, Kento Imajo, Takashi Kobayashi, Yasushi Honda, Takayuki Kato, Yuji Ogawa, Wataru Tomeno, Shingo Kato, Takuma Higurashi, Masato Yoneda, Hiroyuki Kirikoshi, (unknown), Masataka Taguri, Takeharu Yamanaka, Haruki Usuda, Koichiro Wada, Satoru Saito, Atsushi Nakajima	4
4	Palmitate-induced lipotoxicity is crucial for the pathogenesis of nonalcoholic fatty liver disease in cooperation with gut-derived endotoxin 2018 ·Scientific Reports ·Yuji Ogawa, Kento Imajo, Yasushi Honda, Takaomi Kessoku, Wataru Tomeno, Shingo Kato, Koji Fujita, Masato Yoneda, Satoru Saito, Yusuke Saigusa, Hideyuki Hyogo, Yoshio Sumida, Yoshito Itoh, Kosei Eguchi, Takeharu Yamanaka, Koichiro Wada, Atsushi Nakajima	93
5	Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitis 2017 ·Scientific Reports ·Yasushi Honda, Takaomi Kessoku, Yuji Ogawa, Wataru Tomeno, Kento Imajo, Koji Fujita, Masato Yoneda, Toshiaki Takizawa, Satoru Saito, Yoji Nagashima, Atsushi Nakajima	97
6	A case of Castleman disease complicating chronic hepatitis C 2017 ·Kanzo ·Wataru Tomeno, (unknown), (unknown), Yuji Ogawa, Yasushi Honda, Takaomi Kessoku, Kento Imajo, Masato Yoneda, Hiroyuki Kirikoshi, Shoji Yamanaka, Kenichi Ohashi, Atsushi Nakajima, Satoru Saito	0
7	Characteristics of Fecal Microbiota in Japanese Patients with Nonalcoholic Fatty Liver Disease: A Connection among Gut-Permeability, Endotoxin and NAFLD 2017 ·Gastroenterology ·Takaomi Kessoku, Kento Imajo, Yasushi Honda, Takayuki Kato, (unknown), Wataru Tomeno, Takuma Higurashi, Masato Yoneda, (unknown), Yoshiki Tanaka, Tomohiro Kawahara, Satoru Saito, Haruki Usuda, Koichiro Wada, Atsushi Nakajima	5
8	Resveratrol ameliorates fibrosis and inflammation in a mouse model of nonalcoholic steatohepatitis 2016 ·Scientific Reports ·Takaomi Kessoku, Kento Imajo, Yasushi Honda, Takayuki Kato, Yuji Ogawa, Wataru Tomeno, Shingo Kato, Hironori Mawatari, Koji Fujita, Masato Yoneda, Yoji Nagashima, Satoru Saito, Koichiro Wada, Atsushi Nakajima	70
9	A case of liver infarction complicating the HELLP syndrome 2016 ·Kanzo ·Wataru Tomeno, (unknown), Koji Fujita, Kento Imajo, Hironori Mawatari, Masato Yoneda, Hirotoshi Fujikawa, Atsushi Nakajima, Satoru Saito	0
10	Magnetic Resonance Imaging More Accurately Classifies Steatosis and Liver Fibrosis in Non-Alcoholic Fatty Liver Disease than Transient Elastography 2016 ·Journal of Hepatology ·Kento Imajo, (unknown), Takaomi Kessoku, Wataru Tomeno, Yasuhiro Ogawa, Hironori Mawatari, (unknown), Masashi Yoneda, Satomi Saito, Asuka Nakajima	2
11	The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice 2016 ·PLoS ONE ·Yasushi Honda, Kento Imajo, Takayuki Kato, Takaomi Kessoku, Yuji Ogawa, Wataru Tomeno, Shingo Kato, Hironori Mawatari, Koji Fujita, Masato Yoneda, Satoru Saito, Atsushi Nakajima	134
12	Characteristics of non‐obese non‐alcoholic fatty liver disease: Effect of genetic and environmental factors 2016 ·Hepatology Research ·Yasushi Honda, Masato Yoneda, Takaomi Kessoku, Yuji Ogawa, Wataru Tomeno, Kento Imajo, Hironori Mawatari, Koji Fujita, Hideyuki Hyogo, Takato Ueno, Kazuaki Chayama, Satoru Saito, Atsushi Nakajima, Kikuko Hotta	60
13	Non‐alcoholic fatty liver disease comorbid with major depressive disorder: The pathological features and poor therapeutic efficacy 2015 ·Journal of Gastroenterology and Hepatology ·Wataru Tomeno, Keigo Kawashima, Masato Yoneda, Satoru Saito, Yuji Ogawa, Yasushi Honda, Takaomi Kessoku, Kento Imajo, Hironori Mawatari, Koji Fujita, Yoshio Hirayasu, Atsushi Nakajima	76
14	Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography breakdown → 2015 ·Gastroenterology ·Kento Imajo, Takaomi Kessoku, Yasushi Honda, Wataru Tomeno, Yuji Ogawa, Hironori Mawatari, Koji Fujita, Masato Yoneda, Masataka Taguri, Hideyuki Hyogo, Yoshio Sumida, Masafumi Ono, Yuichiro Eguchi, Tomio Inoue, Takeharu Yamanaka, Koichiro Wada, Satoru Saito, Atsushi Nakajima	598
15	Emerging drugs for non-alcoholic steatohepatitis 2013 ·Expert Opinion on Emerging Drugs ·Wataru Tomeno, Masato Yoneda, Kento Imajo, Yuji Ogawa, Takaomi Kessoku, Satoru Saito, Yuichiro Eguchi, Atsushi Nakajima	14
16	Soluble CD14 Levels Reflect Liver Inflammation in Patients with Nonalcoholic Steatohepatitis 2013 ·PLoS ONE ·Yuji Ogawa, Kento Imajo, Masato Yoneda, Takaomi Kessoku, Wataru Tomeno, Yoshiyasu Shinohara, Shingo Kato, Hironori Mawatari, Yuichi Nozaki, Koji Fujita, Hiroyuki Kirikoshi, Shin Maeda, Satoru Saito, Koichiro Wada, Atsushi Nakajima	41
17	Unfolded protein response pathways regulate Hepatitis C virus replication via modulation of autophagy 2013 ·Biochemical and Biophysical Research Communications ·Yoshiyasu Shinohara, Kento Imajo, Masato Yoneda, Wataru Tomeno, Yuji Ogawa, Hiroyuki Kirikoshi, Kengo Funakoshi, Masanori Ikeda, Nobuyuki Kato, Atsushi Nakajima, Satoru Saito	40
18	Oral choline tolerance test as a novel noninvasive method for predicting nonalcoholic steatohepatitis 2013 ·Journal of Gastroenterology ·Kento Imajo, Masato Yoneda, Koji Fujita, Takaomi Kessoku, Wataru Tomeno, Yuji Ogawa, Yoshiyasu Shinohara, Yusuke Sekino, Hironori Mawatari, Yuichi Nozaki, Hiroyuki Kirikoshi, Masataka Taguri, (unknown), Junichiro Takahashi, Satoru Saito, Koichiro Wada, Atsushi Nakajima	10
19	Peroxisome Proliferator-Activated Receptor Gamma Exacerbates Concanavalin A-Induced Liver Injury via Suppressing the Translocation of NF-κB into the Nucleus 2012 ·PPAR Research ·Yuji Ogawa, Masato Yoneda, Wataru Tomeno, Kento Imajo, Yoshiyasu Shinohara, Koji Fujita, Wataru Shibata, Hiroyuki Kirikoshi, Satoru Saito, Koichiro Wada, Shin Maeda, Atsushi Nakajima	11
20	Evaluation of theLiverFibrosisIndex calculated by using real‐time tissue elastography for the non‐invasive assessment of liver fibrosis in chronic liver diseases 2012 ·Hepatology Research ·Wataru Tomeno, Masato Yoneda, Kento Imajo, Kaori Suzuki, Yuji Ogawa, Yoshiyasu Shinohara, Hironori Mawatari, Koji Fujita, Wataru Shibata, Hiroyuki Kirikoshi, Shin Maeda, Atsushi Nakajima, Satoru Saito	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact